Is this study's primary condition wrong?
Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD
- The registry's first term
- Eye Diseases
- ClinicalTrials.gg shows
- Macular Degeneration